MAPT and Alzheimer disease: Typically, patients with severe AD exhibit symptoms such as progressive amnesia and cognitive decline, which can be diagnosed through the presence of amyloid deposits, p-Tau and significant neuronal degeneration, showing promise for clinical and research applications.